Welcome to LookChem.com Sign In|Join Free
  • or
1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole is a complex chemical compound characterized by a benzimidazole ring with a methyl group at the 1 position and a 4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl group at the 6 position. This unique structure endows it with potential applications in various fields, particularly in medicinal chemistry, pharmaceuticals, and agrochemicals.

1107627-01-9

Post Buying Request

1107627-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1107627-01-9 Usage

Uses

Used in Medicinal Chemistry:
1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole is used as a building block in the development of pharmaceuticals for its unique structure and properties. It can be incorporated into drug molecules to enhance their therapeutic effects and target specific biological pathways.
Used in Agrochemicals:
In the agrochemical industry, 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole is used as a component in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure allows for the development of novel compounds with improved efficacy and selectivity.
Used in Organic Synthesis:
1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole serves as a valuable building block in organic synthesis, enabling the creation of a wide range of chemical compounds with diverse applications. Its unique boron-containing group facilitates various synthetic transformations and reactions.
Used as a Research Reagent:
In chemical and biological studies, 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole is used as a research reagent to explore its properties and potential applications. It can be employed in the synthesis of new compounds, evaluation of biological activities, and investigation of reaction mechanisms.
Overall, the unique structure and properties of 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole make it a promising candidate for further study and potential applications in various industries, including medicinal chemistry, pharmaceuticals, agrochemicals, and organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 1107627-01-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,7,6,2 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1107627-01:
(9*1)+(8*1)+(7*0)+(6*7)+(5*6)+(4*2)+(3*7)+(2*0)+(1*1)=119
119 % 10 = 9
So 1107627-01-9 is a valid CAS Registry Number.

1107627-01-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole

1.2 Other means of identification

Product number -
Other names 1-METHYL-1H-BENZIMIDAZOLE-6-BORONIC ACID PINACOL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1107627-01-9 SDS

1107627-01-9Upstream product

1107627-01-9Relevant academic research and scientific papers

PRMT5 INHIBITORS AND USES THEREOF

-

, (2016/04/20)

Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof:wherein Y1 is of formula (?) or formula (y):Ring Y is a 5- to 6-membered heteroaryl ring; and V4, V5, Rx, x, y, and n are as defined herein. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.

PRMT5 INHIBITORS AND USES THEREOF

-

, (2014/07/08)

Described herein are compounds of formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical com-positions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1107627-01-9